KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Revenue (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Revenue for 17 consecutive years, with $2.8 billion as the latest value for Q4 2025.

  • Quarterly Revenue rose 7.06% to $2.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.0 billion through Dec 2025, up 11.78% year-over-year, with the annual reading at $11.0 billion for FY2025, 11.78% up from the prior year.
  • Revenue hit $2.8 billion in Q4 2025 for Quest Diagnostics, roughly flat from $2.8 billion in the prior quarter.
  • In the past five years, Revenue ranged from a high of $2.8 billion in Q3 2025 to a low of $2.3 billion in Q4 2023.
  • Historically, Revenue has averaged $2.5 billion across 5 years, with a median of $2.5 billion in 2021.
  • Biggest five-year swings in Revenue: skyrocketed 49.29% in 2021 and later fell 14.98% in 2022.
  • Year by year, Revenue stood at $2.7 billion in 2021, then dropped by 14.98% to $2.3 billion in 2022, then fell by 1.93% to $2.3 billion in 2023, then grew by 14.55% to $2.6 billion in 2024, then increased by 7.06% to $2.8 billion in 2025.
  • Business Quant data shows Revenue for DGX at $2.8 billion in Q4 2025, $2.8 billion in Q3 2025, and $2.8 billion in Q2 2025.